(HealthDay) -- The third of five people scheduled to get an implanted, self-contained artificial heart received the mechanical device this week at St. Luke's Episcopal Hospital in Houston, CNN News reports.
The AbioCor heart, made by Abiomed Inc. of Danvers, Mass., has been authorized for five people with end-stage heart failure. They are part of the first human trial of the device. Without it, there's a 70 percent chance the patients would die within 30 days, the story says.
The first two recipients of the artificial heart device are doing well, the CNN story says.
